News / Stock

USA: Pharmaceutical industry targeted for inflated medicine prices. Alphie expects a backlash on the stock exchange

Mag 13, 2019 - 16:01 GMT+0000

American pharmaceutical companies are under increasing scrutiny, as accusations are made against them for inflating the prices of some of their generic drugs between 2013-2015. Also, many of the medicines in question cover treatments for cancer and diabetes. The Attorney General leading the investigation William Tong said that the conspiracy amongst generic drug makers to raise the price of medicine explains the high cost of health in the country. In 2018 the pharmaceutical sector reached 1.11trn USD globally according to the Proclinical agency with over 341.1bn USD earned in the United States. alphiewealth’s artificial intelligence has analysed the consequences of…

Register to continue reading for free